Possinger K - Search Results

1

Effect of onapristone and medroxyprogesterone acetate on the proliferation and hormone receptor concentration of human breast cancer cells.

Classen S, Possinger K, Pelka-Fleischer R, Wilmanns W. Classen S, et al. Among authors: possinger k. J Steroid Biochem Mol Biol. 1993 Apr;45(4):315-9. doi: 10.1016/0960-0760(93)90348-z. J Steroid Biochem Mol Biol. 1993. PMID: 8499339

2

Induction of TGF-beta by an antiprogestin in the human breast cancer cell line T-47D.

Dannecker C, Possinger K, Classen S. Dannecker C, et al. Among authors: possinger k. Ann Oncol. 1996 Apr;7(4):391-5. doi: 10.1093/oxfordjournals.annonc.a010606. Ann Oncol. 1996. PMID: 8805931 Free article.

3

[Hormonal therapy of breast carcinoma in women].

Possinger K, Classen S, Beykirch M, Flath B, Wilmanns W. Possinger K, et al. Dtsch Med Wochenschr. 1991 Dec 13;116(50):1921-9. doi: 10.1055/s-2008-1063840. Dtsch Med Wochenschr. 1991. PMID: 1748071 Review. German. No abstract available.

4

Lonidamine in high-risk breast cancer patients.

Possinger K, Wagner H, Kovacs S, Flath B, Classen S, Wilmanns W. Possinger K, et al. Semin Oncol. 1991 Apr;18(2 Suppl 4):58-61. Semin Oncol. 1991. PMID: 2031199 Clinical Trial.

5

Treatment toxicity reduction: breast cancer.

Possinger K, Wagner H, Langecker P, Wilmanns W. Possinger K, et al. Cancer Treat Rev. 1987 Dec;14(3-4):263-74. doi: 10.1016/0305-7372(87)90017-x. Cancer Treat Rev. 1987. PMID: 3326666 Review.

6

[Palliative therapeutic control of tumor progression in patients with metastatic breast cancer].

Possinger K, Wilmanns W. Possinger K, et al. Internist (Berl). 1993 Apr;34(4):340-50. Internist (Berl). 1993. PMID: 7683634 Review. German. No abstract available.

7

Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormone- or chemotherapy in patients with metastatic breast cancer.

Kopp R, Classen S, Wolf H, Gholam P, Possinger K, Wilmanns W. Kopp R, et al. Among authors: possinger k. Anticancer Res. 2001 Jul-Aug;21(4B):2995-3000. Anticancer Res. 2001. PMID: 11712800

8

Clinical relevance of soluble c-erbB-2 for patients with metastatic breast cancer predicting the response to second-line hormone or chemotherapy.

Classen S, Kopp R, Possinger K, Weidenhagen R, Eiermann W, Wilmanns W. Classen S, et al. Among authors: possinger k. Tumour Biol. 2002 Mar-Apr;23(2):70-5. doi: 10.1159/000059706. Tumour Biol. 2002. PMID: 12065844 Free article.

9

[Hormone therapy in metastasized breast cancer. Criteria for establishing indications and implementing high-dose medroxyprogesterone acetate therapy].

Possinger K, Wagner H, Langecker P, Schmid L, Willich S, Wilmanns W. Possinger K, et al. Fortschr Med. 1987 Jul 30;105(22):421-4. Fortschr Med. 1987. PMID: 2958397 German. No abstract available.

10

[Chemotherapy of metastasized breast carcinoma].

Possinger K, Sauer HJ, Wilmanns W. Possinger K, et al. Dtsch Med Wochenschr. 1988 Feb 12;113(6):224-31. doi: 10.1055/s-2008-1067624. Dtsch Med Wochenschr. 1988. PMID: 3276496 Review. German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

253 results

Search Page

Filters